Skip to main content
. 2017 Nov 16;8(4):413–423. doi: 10.1177/2192568217737317

Table 1.

Study and Baseline Participant Characteristics for Included Trials Reporting 5-Year Follow-up Data.

Study; ClinicalTrials.gov Identifier Treatment Blinding Analysis Set N 5-Year LTFU (%) Mean Age (Years) Prior Spinal Surgery Mean BMI (kg/m2) Single-Level Surgery (%) L4/5 Level Treated (%) L5/S1 Level Treated (%) Mean Baseline ODI Scorea Mean Baseline Back Pain Scoreb Preoperative Work Status (% Working)
Gornet 2010; NCT00635843 Maverick Open ITT 577 27% 40 28% 100% 24% 75% 54% 72 60%
ALIF
Guyer 2009; NCT00215332 Charité Singlec ITT 304 43% 39.6 34% 26 100% 30% 69% 51% 72 53%
ALIF
Skold 2013 Charité, ProDisc, Maverick singlea ITT 152 1% 39.4 12% 51% 41% 60 31%
PLIF/PLF
Zigler 2012; NCT00295009 ProDisc-L Singlec ITT 292 18% 39 34% 27 100% 32% 65% 63% 76
CF

Abbreviations: —, not reported; LTFU, loss to follow-up; BMI, body mass index; ODI, Oswestry Disability Index; ITT, intention to treat; ALIF, anterior lumbar interbody fusion; PLIF, posterior lumbar interbody fusion; PLF, posterior lumbar fusion; VAS, Visual Analogue Scale; NRS, Numerical Rating Scale.

aODI questionnaire v2.0 was used in Gornet 2010, Guyer 2009, and Skold 2013, and a modified ODI questionnaire was used in Zigler 2012.

bVAS pain scale (in mm) was used in Guyer 2009, Skold 2013, and Zigler 2012, and the NRS pain scale was used in Gornet 2010.

cParticipants were preoperatively blinded.